Finally, to illustrate any differences, or lack thereof, in antigen-specific CD8+ T cell responses between drug groups, we plotted the samples from the RA cohort at 2–6 weeks post dose 3 (Fig. 5d,e). Here, CD8A is linked to rheumatoid arthritis.